Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $75.3200 (-1.22%) ($75.1400 - $77.0200) on Fri. Jul. 19, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2% (three month average) | RSI | 44 | Latest Price | $75.3200(-1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | UTHR declines -0.3% a day on average for past five trading days. | Weekly Trend | UTHR declines -3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(43%) IBB(41%) VFMO(40%) VYM(40%) XBI(40%) | Factors Impacting UTHR price | UTHR will decline at least -1% in a week (0% probabilities). VIXM(-29%) VXX(-20%) TLT(-13%) IFRA(-4%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1% (StdDev 2%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
1 - 5 Day Possible Target | $70.46(-6.45%) | Resistance Level | $77.96 | 5 Day Moving Average | $75.96(-0.84%) | 10 Day Moving Average | $77.03(-2.22%) | 20 Day Moving Average | $77.96(-3.39%) | To recent high | -28.2% | To recent low | 0% | Market Cap | $3.341b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |